Description

HGH Fragment 176-191 is a synthetic peptide derived from amino acids 176 through 191 of the human growth hormone (HGH) sequence. In controlled laboratory environments, this fragment is studied for its selective interaction with metabolic signaling pathways distinct from full-length growth hormone activity.

Unlike complete HGH molecules, Fragment 176-191 is structurally designed to isolate specific receptor-binding regions for targeted pathway research. In preclinical and in vitro research models, it is commonly utilized to investigate:

Lipolytic signaling pathway analysis

Adipocyte metabolic modeling

Growth hormone receptor fragment interaction studies

Energy regulation research frameworks

Fat metabolism–associated signaling mechanisms

Its truncated structure allows researchers to evaluate discrete biochemical interactions while minimizing broader endocrine pathway activation seen with full-length growth hormone analogs.

HGH Fragment 176-191 is supplied in lyophilized form to ensure stability, storage integrity, and reproducibility in laboratory settings.

Strictly intended for laboratory research use only. Not for human or veterinary use.